Emeric joined Angelini Ventures as an Investor in July 2026. Prior to joining Angelini Ventures, Emeric spent two years at Wellington Partners, as an Associate he supported due diligence for investments in Nuclidium and Beren Therapeutics and worked closely with portfolio companies through two Board Observer roles. Before Wellington, he was a Junior Analyst at Andera Partners and at Bpifrance Large Venture, the growth equity fund of the French public investment bank, contributing to due diligence and portfolio management across life sciences investments.

Emeric also gained valuable industry and clinical experience through internships at Alexion Pharmaceuticals, focusing on rare diseases, and at Rothschild Hospital, where he worked in dermatology and geriatric care. He holds a PharmD from Université Paris Cité and a Master's in Management from ESSEC Business School.